Boston Scientific stockholder files Form 144 to sell 2,901 shares

Boston Scientific Corporation (BSX): Stockholder Ellen M. Zane filed a Form 144 indicating a proposed sale of 2,901 common shares through Wells Fargo Clearing Services on the NYSE, with an aggregate market value of $296,591.81.

Rhea-AI Filing Summary

Boston Scientific Corporation (BSX): Stockholder Ellen M. Zane filed a Form 144 indicating a proposed sale of 2,901 common shares through Wells Fargo Clearing Services on the NYSE, with an aggregate market value of $296,591.81. The filing lists 1,481,751,634 shares outstanding and an approximate sale date of 10/28/2025.

The shares to be sold were acquired via a stock grant on 05/01/2025 in the amount of 2,901. The filing also notes sales during the past three months: on 10/27/2025, Zane sold 9,990 shares for $1,008,081.00 in gross proceeds.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does BSX’s latest Form 144 filing disclose?

A stockholder, Ellen M. Zane, filed to sell 2,901 BSX common shares with an aggregate market value of $296,591.81.

Who is the selling stockholder named in the BSX Form 144?

The filing identifies Ellen M. Zane as the selling stockholder.

How many BSX shares are proposed for sale and when?

The notice covers 2,901 shares with an approximate sale date of 10/28/2025.

What is the aggregate market value of the proposed BSX share sale?

The filing lists an aggregate market value of $296,591.81 for the 2,901 shares.

How were the shares to be sold acquired?

They were acquired via a stock grant on 05/01/2025 in the amount of 2,901 shares.

Were there recent BSX share sales by this stockholder?

Yes. On 10/27/2025, Zane sold 9,990 shares for $1,008,081.00 in gross proceeds.

Which broker and exchange are listed for the proposed sale?

The filing lists Wells Fargo Clearing Services and the NYSE.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 10/28/2025 - 10:55 AM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001369850
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	BOSTON SCIENTIFIC CORP
SEC File Number	001-11083
Address of Issuer	300 BOSTON SCIENTIFIC WAY MARLBOROUGH MASSACHUSETTS 01752-1234
Phone	508-683-4000
Name of Person for Whose Account the Securities are To Be Sold	Zane Ellen M
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
common	Wells Fargo Clearing Services 1 North Jefferson Avenue St. Louis MO 63103	2901	296591.81	1481751634	10/28/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
common	05/01/2025	Stock Grant	Issuer			2901	05/01/2025	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Ellen M Zane 300 Boston Scientific Way Marlborough MA 01752	Boston Scientific Corporation	10/27/2025	9990	1008081.00

144: Remarks and Signature

Remarks	shares were sold in the Ellen Zane Family Trust, Ellen M Zane, trustee.
Date of Notice	10/28/2025
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	07/25/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Ellen M Zane
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)